Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bepotastine salicylate is a **salt form of bepotastine**, an antihistamine used primarily for allergic conditions, formed between one molecule of bepotastine and one molecule of salicylic acid. The compound crystallizes in an anhydrous form, frequently used for pharmaceutical manufacturing. Bepotastine itself is a **non-sedating, selective antagonist of the histamine H1 receptor**, acts as a mast cell stabilizer, and suppresses migration of eosinophils, providing anti-allergic and anti-inflammatory effects. The salicylate form is primarily relevant as an **intermediate or alternative salt** for formulation or manufacturing rather than as a marketed drug product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bepotastine salicylate.